{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:24:47Z","timestamp":1789583087923,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872375"],"award-info":[{"award-number":["81872375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172863"],"award-info":[{"award-number":["82172863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010118"],"award-info":[{"award-number":["2021A1515010118"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00432-022-04355-w","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T03:36:33Z","timestamp":1666841793000},"page":"2327-2344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Concurrent chemoradiotherapy combined with nimotuzumab in stage III\u2013IVa nasopharyngeal carcinoma: a retrospective analysis"],"prefix":"10.1007","volume":"149","author":[{"given":"Zhuochen","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenze","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chixiong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-6853","authenticated-orcid":false,"given":"Xing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"4355_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1349-7006.2008.00836.x","volume":"99","author":"BYM Brigette","year":"2008","unstructured":"Brigette BYM, Edwin PH, Anthony TCC (2008) Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci 99:1311\u20131318. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00836.x","journal-title":"Cancer Sci"},{"key":"4355_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1380-2933(97)00065-1","volume":"3","author":"M Cristina","year":"1997","unstructured":"Cristina M, Ernest M, Kathryn A, Josefa L, William H, Rolando P (1997) Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology 3:71\u201381","journal-title":"Immunotechnology"},{"key":"4355_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ijc.10647","volume":"101","author":"T Crombet-Ramos","year":"2002","unstructured":"Crombet-Ramos T, Rak J, Perez R, Viloria-Petit A (2002) Antiproliferative, antiangiogenic and proapoptotic activity of h-R3: a humanized anti-EGFR antibody. Int J Cancer 101:567\u2013575. https:\/\/doi.org\/10.1002\/ijc.10647","journal-title":"Int J Cancer"},{"key":"4355_CR4","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1200\/JCO.2012.41.8343","volume":"30","author":"H Dong-Seok","year":"2012","unstructured":"Dong-Seok H, Yun-Suhk S, Seong-Ho K, Hyuk-Joon L, Yunhee C, Susumu A, Takeshi S, Byung-Joo P, Woo-Ho K, Yang H-K (2012) Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol 30:3834\u20133840. https:\/\/doi.org\/10.1200\/JCO.2012.41.8343","journal-title":"J Clin Oncol"},{"key":"4355_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40265-013-0025-3","volume":"73","author":"K Dorsey","year":"2013","unstructured":"Dorsey K, Agulnik M (2013) Promising new molecular targeted therapies in head and neck cancer. Drugs 73:315\u2013325. https:\/\/doi.org\/10.1007\/s40265-013-0025-3","journal-title":"Drugs"},{"key":"4355_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3727\/096504017x15079846743590","volume":"26","author":"W Fangzheng","year":"2018","unstructured":"Fangzheng W, Chuner J, Zhiming Y, Tongxin L, Fengqin Y, Lei W, Bin L, Fujun H, Ming C, Weifeng Q, Zhenfu F (2018a) Long-term use of nimotuzumab in combination with intensity-modulated radiotherapy and chemotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma: experience of a single institution. Oncol Res Featuring Preclin Clin Cancer Ther 26:277\u2013287. https:\/\/doi.org\/10.3727\/096504017x15079846743590","journal-title":"Oncol Res Featuring Preclin Clin Cancer Ther"},{"key":"4355_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.7150\/jca.20461","volume":"9","author":"W Fangzheng","year":"2018","unstructured":"Fangzheng W, Quanquan S, Chuner J, Tongxin L, Aizawa R, Sakamoto M, Yuezhen W, Zhenfu F, Chen M (2018b) Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis. J Cancer 9:594\u2013603. https:\/\/doi.org\/10.7150\/jca.20461","journal-title":"J Cancer"},{"key":"4355_CR8","first-page":"2958","volume":"7","author":"C Fortunato","year":"2001","unstructured":"Fortunato C, Giampaolo T (2001) A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7:2958\u20132970","journal-title":"Clin Cancer Res"},{"key":"4355_CR9","doi-asserted-by":"publisher","unstructured":"Jian Ji P, Wai Tong N, Jing Feng Z, Lucy L. K. C, Brian O\u2019s, Shao Jun L, Henry C. K. S, Yun Bin C, Horace C.W. C, Qiao Juan G, Wai Kuen K, You Ping X, Xu W, Quynh Thu L, Christine M. G, A. Dimitrios C, Randal S. W, Jatin P. S,Anne W. M. L (2016) Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122:546\u2013558. https:\/\/doi.org\/10.1002\/cncr.29795.","DOI":"10.1002\/cncr.29795"},{"key":"4355_CR10","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.18632\/oncotarget.13899","volume":"8","author":"H Jian-Feng","year":"2017","unstructured":"Jian-Feng H, Fu-Zheng Z, Qin-Zhou Z, Le-Yuan Z, Bo Y, Jian-Jun C, Jia-Hua Y, Hao-Wen Z, Xiao-Peng Y, Guo-Mei T, Fen-Ju L, Charlie MC-M (2017) Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial. Oncotarget 8:2754\u20132465. https:\/\/doi.org\/10.18632\/oncotarget.13899","journal-title":"Oncotarget"},{"key":"4355_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7150\/ijbs.24374","volume":"14","author":"L Jianpei","year":"2018","unstructured":"Jianpei L, Shulin C, Songguo P, Yijun L, Shan X, Xia H, Chen H (2018) Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics. Int J of Biol Sci 14:549\u2013556. https:\/\/doi.org\/10.7150\/ijbs.24374","journal-title":"Int J of Biol Sci"},{"key":"4355_CR12","first-page":"4059","volume":"24","author":"S Jian-Yong","year":"2004","unstructured":"Jian-Yong S, Yu Z, Yu-Hong L, Hong-Yi G, Hui-Xia F, Qiu-Liang W, Nian-Ji C, Gang C, Bin H, Li-Fu H, Ingemar E, Yi-Xin Z (2004) Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Anticancer Res 24:4059\u20134066","journal-title":"Anticancer Res"},{"key":"4355_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1080\/15384047.2018.1491501","volume":"19","author":"Y Ji-Jin","year":"2018","unstructured":"Ji-Jin Y, Guan-Qun Z, Si-Yang W, Lu-Lu Z, Tian-Sheng G, Ying-Lin P, Wayne RL, Ying S, Wang-Jian Z, Fan Z (2018) Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer Biol Ther 19:1102\u20131107. https:\/\/doi.org\/10.1080\/15384047.2018.1491501","journal-title":"Cancer Biol Ther"},{"key":"4355_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.2006.06.1218","volume":"25","author":"PI Karakiewicz","year":"2007","unstructured":"Karakiewicz PI, Briganti A, Chun FK, Trinh QD, Perrotte P, Ficarra V, Cindolo L, De La Taille A, Tostain J, Mulders PF, Salomon L, Zigeuner R, Prayer-Galetti T, Chautard D, Valeri A, Lechevallier E, Descotes JL, Lang H, Mejean A, Patard JJ (2007) Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25:1316\u20131322. https:\/\/doi.org\/10.1200\/JCO.2006.06.1218","journal-title":"J Clin Oncol"},{"key":"4355_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ncpuro0968","volume":"4","author":"MW Kattan","year":"2007","unstructured":"Kattan MW, Scardino PT (2007) Evidence for the usefulness of nomograms. Nat Clin Pract Urol 4:638\u2013639. https:\/\/doi.org\/10.1038\/ncpuro0968","journal-title":"Nat Clin Pract Urol"},{"key":"4355_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","volume":"61","author":"AW Lee","year":"2005","unstructured":"Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL, Lau WH (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61:1107\u20131116. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.07.702","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4355_CR17","doi-asserted-by":"publisher","unstructured":"Lei C, Chao-Su H, Xiao-Zhong Chen, Guo-Qing H, Zhi-Bin C, Yan S, Wei-Xiong L, Yuan-Yuan C, Fang-Yun X, Shao-Bo L, Yong C, Ting-Ting X, Bin L, Guo-Xian L, Si-Yang W, Bao-Min Z, Ying G, Ying S, Yan-Ping M, Ling-Long T, Yu-Ming C, Meng-Zhong L,M J(2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. The Lancet Oncology 13:163-171. https:\/\/doi.org\/10.1016\/s1470-2045(11)70320-5","DOI":"10.1016\/s1470-2045(11)70320-5"},{"key":"4355_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2974-x","author":"HM Li","year":"2016","unstructured":"Li HM, Li P, Qian YJ, Wu X, Xie L, Wang F, Zhang H, Liu L (2016) A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-016-2974-x","journal-title":"BMC Cancer"},{"key":"4355_CR19","doi-asserted-by":"publisher","unstructured":"Ling-Long T, Lei C, Li T, Yu-Pei C, Yan-Ping M, Ai-Hua L, Li L, Zi-Xian W, Ying S, Jun M, Rui G(2017) Validation of the 8th Edition of the UICC\/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era. J Natl Compr Canc Netw 15:913\u2013919. https:\/\/doi.org\/10.6004\/jnccn.2017.0121.","DOI":"10.6004\/jnccn.2017.0121"},{"key":"4355_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv291","author":"T Lin-Quan","year":"2015","unstructured":"Lin-Quan T, Chao-Feng L, Jing L, Wen-Hui C, Qiu-Yan C, Lian-Xiong Y, Xiao-Ping L, Yun H, Yun-Xiu-Xiu X, Dong-Peng H, Shi-Hua W, Yu-Tuan P, Lu Z, Shan-Shan G, Li-Ting L, Ling G, Yi-Shan W, Dong-Hua L, Pei-Yu H, Hao-Yuan M, Yan-Qun X, Rui S, Ming-Yuan C, Yi-Jun H, Xing L, Lin W, Chong Z, Ka-Jia C, Chao-Nan Q, Xiang G, Yi-Xin Z, Hai-Qiang M, Mu-Sheng Z (2015) Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv291","journal-title":"J Natl Cancer Inst"},{"key":"4355_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/cncr.20778","volume":"103","author":"L Mariani","year":"2005","unstructured":"Mariani L, Miceli R, Kattan MW, Brennan MF, Colecchia M, Fiore M, Casali PG, Gronchi A (2005) Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 103:402\u2013408. https:\/\/doi.org\/10.1002\/cncr.20778","journal-title":"Cancer"},{"key":"4355_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.03.002","volume":"80","author":"L Mei","year":"2018","unstructured":"Mei L, Rui Y, You-Ping L, Yi-Nuan Z, Hao-Jiong Z, Xiong Z, Qi Y, Li C-F, Yi-Jun H, Tao Y, Jing-Yu C, Ji-Bin L, Hao-Yuan M, Ling G, Ai-Hua L, Ying S, Chao-Nan Q, Jun M, Hai-Qiang M, Ming-Yuan C (2018) Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma. Oral Oncol 80:1\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.03.002","journal-title":"Oral Oncol"},{"key":"4355_CR23","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","volume":"51","author":"Z Meng-Xia","year":"2015","unstructured":"Meng-Xia Z, Jing L, Guo-Ping XZ, Jun-Jie X, Rou J, Rui Y, Yi-Jun H, Ying S, Jun M, Ming-Huang H, Ming-Yuan C (2015) Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer 51:2587\u20132595. https:\/\/doi.org\/10.1016\/j.ejca.2015.08.006","journal-title":"Eur J Cancer"},{"key":"4355_CR24","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1002\/cncr.32179","volume":"125","author":"VM Patil","year":"2019","unstructured":"Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D\u2019cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K (2019) A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer. Cancer 125:3184\u20133197. https:\/\/doi.org\/10.1002\/cncr.32179","journal-title":"Cancer"},{"key":"4355_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11523-013-0281-x","volume":"8","author":"H Prenen","year":"2013","unstructured":"Prenen H, Vecchione L, Van Cutsem E (2013) Role of targeted agents in metastatic colorectal cancer. Target Oncol 8:83\u201396. https:\/\/doi.org\/10.1007\/s11523-013-0281-x","journal-title":"Target Oncol"},{"key":"4355_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.oraloncology.2013.11.008","volume":"50","author":"BKM Reddy","year":"2014","unstructured":"Reddy BKM, Lokesh V, Vidyasagar MS, Shenoy K, Babu KG, Shenoy A, Naveen T, Joseph B, Bonanthaya R, Nanjundappa BPP, Loknatha SJ, Prasad K, Tanvir Pasha CR (2014) Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in Indian patients. Oral Oncol 50:498\u2013505. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.11.008","journal-title":"Oral Oncol"},{"key":"4355_CR27","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"LC Robert","year":"2004","unstructured":"Robert LC, David LR, Marisa Dolled F (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713","journal-title":"Clin Cancer Res"},{"key":"4355_CR28","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/ijc.30819","volume":"141","author":"Y Rui","year":"2017","unstructured":"Rui Y, Rui S, Yi-Jun H, Chao-Feng L, Ji-Bin L, Xiong Z, Qi Y, You-Ping L, Yi-Nuan Z, Tao Y, Jing-Yu C, Meng-Xia Z, Rou J, Hao-Yuan M, Ling G, Ka-Jia C, Ai-Hua L, Chao-Nan Q, Ying S, Jun M, Ming-Yuan C (2017a) Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II\u2013IVb nasopharyngeal carcinoma. Int J Cancer 141:1265\u20131276. https:\/\/doi.org\/10.1002\/ijc.30819","journal-title":"Int J Cancer"},{"key":"4355_CR29","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.7150\/thno.19710","volume":"7","author":"Y Rui","year":"2017","unstructured":"Rui Y, Yi-Jun H, You-Ping L, Qi Y, Yi-Nuan Z, Ji-Bin L, Chao-Feng L, Xiong Z, Tao Y, Jing-Yu C, Meng-Xia Z, Rou J, Rui S, Hao-Yuan M, Ling G, Ka-Jia C, Ai-Hua L, Ying S, Chao-Nan Q, Jun M, Ming-Yuan C (2017b) Concurrent chemoradiotherapy with or without anti-EGFR-targeted treatment for stage II-IVb nasopharyngeal carcinoma: retrospective analysis with a large cohort and long follow-up. Theranostics 7:2314\u20132324. https:\/\/doi.org\/10.7150\/thno.19710","journal-title":"Theranostics"},{"key":"4355_CR30","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1158\/0008-5472.CAN-08-4518","volume":"69","author":"A Talavera","year":"2009","unstructured":"Talavera A, Friemann R, Gomez-Puerta S, Martinez-Fleites C, Garrido G, Rabasa A, Lopez-Requena A, Pupo A, Johansen RF, Sanchez O, Krengel U, Moreno E (2009) Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Cancer Res 69:5851\u20135859. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4518","journal-title":"Cancer Res"},{"key":"4355_CR31","doi-asserted-by":"publisher","unstructured":"Tania C, Leonel T, Elia N, Mauricio C, Mar\u0131\u00b4a E. S, Alejandro P, Olga T, Normando I, Franz T, Rolando P, L AN (2003) Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer. J Immunother 26:139-148. https:\/\/doi.org\/10.1097\/00002371-200303000-00006","DOI":"10.1097\/00002371-200303000-00006"},{"key":"4355_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijrobp.2020.08.045","volume":"109","author":"L Wang-Zhong","year":"2021","unstructured":"Wang-Zhong L, Shu-Hui L, Guo-Ying L, Hu L, Xiang G, Xing L, Kui-Yuan L, Meng-Yun Q, Xi C, Zg S, Chang-Qing X, Wei-Xiong X, Xiang Y-Q (2021) Development of a prognostic model to identify the suitable definitive radiation therapy candidates in de novo metastatic nasopharyngeal carcinoma: a real-world study. Int J Radiat Oncol Biol Phys 109:120\u2013130. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4355_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.oraloncology.2017.02.026","volume":"67","author":"X Wei-Xiong","year":"2017","unstructured":"Wei-Xiong X, Hu L, Xing L, Lin W, Chao-Nan Q, Yan-Fang Y, Liang-Ru K, Wen-Ze Q, Ya-Hui Y, Xin-Jun H, Guo-Ying L, Chong Z, Yan-Qun X, Xiang G (2017) Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a propensity score analysis. Oral Oncol 67:167\u2013174. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.02.026","journal-title":"Oral Oncol"},{"key":"4355_CR34","doi-asserted-by":"crossref","unstructured":"William ML, Patel SG, Brian O\u2019sullivan, Margaret S. Brandwein, John A. Ridge M, Jocelyn C. Migliacci, Ashley M. Loomis,Shah JP (2017) Head and neck cancers-major changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J Clin 67:122\u2013137.","DOI":"10.3322\/caac.21389"},{"key":"4355_CR35","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2217\/fon.13.151","volume":"9","author":"H Xia","year":"2013","unstructured":"Xia H, Jianhua X, Wenjie G, Xuesong J, Xue W, Dan Z (2013) Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results. Future Oncol 9:1459\u20131467. https:\/\/doi.org\/10.2217\/fon.13.151","journal-title":"Future Oncol"},{"key":"4355_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.oraloncology.2015.06.008","volume":"51","author":"T Xu","year":"2015","unstructured":"Xu T, Liu Y, Dou S, Li F, Guan X, Zhu G (2015) Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study. Oral Oncol 51:875\u2013879. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.06.008","journal-title":"Oral Oncol"},{"key":"4355_CR37","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.2147\/dddt.S215190","volume":"13","author":"S Xue-Song","year":"2019","unstructured":"Xue-Song S, Yu-Jing L, Xiao-Yun L, Sai-Lan L, Qiu-Yan C, Lin-Quan T, Hai-Qiang M (2019) Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study. Drug Des Dev Ther 13:3207\u20133216. https:\/\/doi.org\/10.2147\/dddt.S215190","journal-title":"Drug Des Dev Ther"},{"key":"4355_CR38","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.3892\/ol.2017.7186","volume":"14","author":"H Yan","year":"2017","unstructured":"Yan H, Cao X, Wang J (2017) Application of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Oncol Lett 14:7773\u20137776. https:\/\/doi.org\/10.3892\/ol.2017.7186","journal-title":"Oncol Lett"},{"key":"4355_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3552-6","author":"L Yang","year":"2017","unstructured":"Yang L, Qiu-Yan C, Lin-Quan T, Li-Ting L, Shan-Shan G, Ling G, Hao-Yuan M, Ming-Yuan C, Xiang G, Ka-Jia C, Chao-Nan Q, Mu-Shen Z, Jin-Xin B, Jian-Yong S, Ying S, Jing T, Shuai C, Jun M, Chong Z, Hai-Qiang M (2017) Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case\u2013control study. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-017-3552-6","journal-title":"BMC Cancer"},{"key":"4355_CR40","doi-asserted-by":"publisher","first-page":"8690","DOI":"10.1016\/j.biomaterials.2013.07.100","volume":"34","author":"C Yewale","year":"2013","unstructured":"Yewale C, Baradia D, Vhora I, Patil S, Misra A (2013) Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 34:8690\u20138707. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.07.100","journal-title":"Biomaterials"},{"key":"4355_CR41","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/s1470-2045(16)30410-7","volume":"17","author":"S Ying","year":"2016","unstructured":"Ying S, Wen-Fei L, Nian-Yong C, Ning Z, Guo-Qing H, Fang-Yun X, Yan S, Xiao-Zhong C, Jin-Gao L, Xiao-Dong Z, Chao-Su H, Xiang-Ying X, Yuan-Yuan C, Wei-Han H, Ling G, Hao-Yuan M, Lei C, Yan-Ping M, Rui S, Ping A, Shao-Bo L, Guo-Xian L, Bao-Min Z, Xing-Lai F, Xiao-Chang G, Ling L, Chun-Ying S, Jian-Yu X, Ying G, Yu-Ming C, Fan Z, Li L, Ling-Long T, Meng-Zhong L, M J, (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol 17:1509\u20131520. https:\/\/doi.org\/10.1016\/s1470-2045(16)30410-7","journal-title":"Lancet Oncol"},{"key":"4355_CR42","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"W Yizhou","year":"2013","unstructured":"Yizhou W, Jun L, Yong X, Renyan G, Kui W, Zhenlin Y, Xuying W, Guanghua L, Dong W, Lehua S, Wanyee L, Mengchao W, Shen F (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188\u20131195. https:\/\/doi.org\/10.1200\/JCO.2012.41.5984","journal-title":"J Clin Oncol"},{"key":"4355_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.radonc.2017.12.002","volume":"129","author":"Z Yuan","year":"2018","unstructured":"Yuan Z, Wen-Fei L, Xu L, Lei C, Rui S, Ying S, Qing L, Jun M (2018) Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: analysis of a multicenter, phase III randomized trial. Radiother Oncol 129:18\u201322. https:\/\/doi.org\/10.1016\/j.radonc.2017.12.002","journal-title":"Radiother Oncol"},{"key":"4355_CR44","doi-asserted-by":"publisher","unstructured":"Yu-Pei C, Nofisat I, Melvin L. K. C, A. Dimitrios C, Robert H, Shao-Hui H, Joseph T. S. W, Alexander C. Whitley, Jun-Lin Y, Sue S. Y, Anthony T. C. C, Chao-Su H, Jin-Yi L, Quynhthu L, Anne W. M. L, Nancy L, Jinching L, Brigette M, Thomas J. M, Jatin S, Ying S,Jun M(2021) Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline. Journal of Clinical Oncology 39:840-859. https:\/\/doi.org\/10.1200\/JCO.20","DOI":"10.1200\/JCO.20"},{"key":"4355_CR45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8225","author":"L Zhi-Gang","year":"2016","unstructured":"Zhi-Gang L, Yu Z, Jiao T, Yu-Juan Z, Wen-Juan Y, Yan-Fang Q, Hui W (2016) Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.8225","journal-title":"Oncotarget"},{"key":"4355_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6156-5","author":"W Zhi-Qiang","year":"2019","unstructured":"Zhi-Qiang W, Qi M, Ji-Bin L, Rui Y, You-Ping L, Rui S, Guang-Yuan H, Ming-Yuan C, Yi-Jun H (2019) The long-term survival of patients with III\u2013IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-019-6156-5","journal-title":"BMC Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04355-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04355-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04355-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T10:10:59Z","timestamp":1682417459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04355-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4355"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04355-w","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conflict of interest relevant to this article was not reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by the Clinical Research Committee of Sun Yat-sen University Cancer Center (B2021-366-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from each patient for the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}